Literature DB >> 24058221

Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database.

Jules T Mitchel1, Yong Joong Kim, Joonhyuk Choi, Glen Park, Silvana Cappi, David Horn, Morgan Kist, Ralph B D Agostino.   

Abstract

Monitoring of clinical trials includes several disciplines, stakeholders, and skill sets. The aim of the present study was to identify database changes and data entry errors to an electronic data capture (EDC) clinical trial database, and to access the impact of the changes. To accomblish the aim, Target e*CRF was used as the EDC tool for a multinational, dose-finding, multicenter, double-blind, randomized, parallel, placebo-controlled trial to investigate efficacy and safety of a new treatment in men with lower urinary tract symptoms associated with benign prostatic hyperplasia. The main errors observed were simple transcription errors from the paper source documents to the EDC database. This observation was to be expected, since every transaction has an inherant error rate. What and how to monitor must be assessed within the risk-based monitoring section of the comprehensive data monitoring plan. With the advent of direct data entry, and the elimination of the requirement to transcribe from a paper source record to an EDC system, error rates should go down dramatically. In addition, protocol violations and data outside the normal range can be identified at the time of data entry and not days, weeks, and months after the fact.

Entities:  

Keywords:  Data management; EDC; Risk-based monitoring

Year:  2011        PMID: 24058221      PMCID: PMC3777611          DOI: 10.1177/009286151104500404

Source DB:  PubMed          Journal:  Drug Inf J        ISSN: 0092-8615


  4 in total

Review 1.  The other side of clinical trial monitoring; assuring data quality and procedural adherence.

Authors:  George W Williams
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

Review 2.  Developing systems for cost-effective auditing of clinical trials.

Authors:  R M Califf; S L Karnash; L H Woodlief
Journal:  Control Clin Trials       Date:  1997-12

3.  Reducing the costs of phase III cardiovascular clinical trials.

Authors:  Eric L Eisenstein; Philip W Lemons; Barbara E Tardiff; Kevin A Schulman; M King Jolly; Robert M Califf
Journal:  Am Heart J       Date:  2005-03       Impact factor: 4.749

4.  Sensible approaches for reducing clinical trial costs.

Authors:  Eric L Eisenstein; Rory Collins; Beena S Cracknell; Oscar Podesta; Elizabeth D Reid; Peter Sandercock; Yuriy Shakhov; Michael L Terrin; Mary Ann Sellers; Robert M Califf; Christopher B Granger; Rafael Diaz
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

  4 in total
  11 in total

Review 1.  The impact of clinical trial monitoring approaches on data integrity and cost--a review of current literature.

Authors:  Rasmus Olsen; Asger Reinstrup Bihlet; Faidra Kalakou; Jeppe Ragnar Andersen
Journal:  Eur J Clin Pharmacol       Date:  2016-01-04       Impact factor: 2.953

2.  INVESTIGATING THE EFFICACY OF CLINICAL TRIAL MONITORING STRATEGIES: Design and Implementation of the Cluster Randomized START Monitoring Substudy.

Authors:  Katherine Huppler Hullsiek; Jonathan M Kagan; Nicole Engen; Jesper Grarup; Fleur Hudson; Eileen T Denning; Catherine Carey; David Courtney-Rodgers; Elizabeth B Finley; Per O Jansson; Mary T Pearson; Dwight E Peavy; Waldo H Belloso
Journal:  Ther Innov Regul Sci       Date:  2015-03-01       Impact factor: 1.778

3.  A spectrum of sharing: maximization of information content for brain imaging data.

Authors:  Vince D Calhoun
Journal:  Gigascience       Date:  2015-01-29       Impact factor: 6.524

4.  High quality standards for a large-scale prospective population-based observational cohort: Constances.

Authors:  Fabrice Ruiz; Marcel Goldberg; Sylvie Lemonnier; Anna Ozguler; Evelyne Boos; Alain Brigand; Violaine Giraud; Thierry Perez; Nicolas Roche; Marie Zins
Journal:  BMC Public Health       Date:  2016-08-25       Impact factor: 3.295

5.  Understanding the barriers to successful adoption and use of a mobile health information system in a community health center in São Paulo, Brazil: a cohort study.

Authors:  Jayant V Rajan; Juliana Moura; Gato Gourley; Karina Kiso; Alexandre Sizilio; Ana Maria Cortez; Lee W Riley; Maria Amelia Veras; Urmimala Sarkar
Journal:  BMC Med Inform Decis Mak       Date:  2016-11-17       Impact factor: 2.796

6.  Risk-adapted monitoring is not inferior to extensive on-site monitoring: Results of the ADAMON cluster-randomised study.

Authors:  Oana Brosteanu; Gabriele Schwarz; Peggy Houben; Ursula Paulus; Anke Strenge-Hesse; Ulrike Zettelmeyer; Anja Schneider; Dirk Hasenclever
Journal:  Clin Trials       Date:  2017-08-08       Impact factor: 2.486

Review 7.  Electronic case report forms and electronic data capture within clinical trials and pharmacoepidemiology.

Authors:  David A Rorie; Robert W V Flynn; Kerr Grieve; Alexander Doney; Isla Mackenzie; Thomas M MacDonald; Amy Rogers
Journal:  Br J Clin Pharmacol       Date:  2017-04-22       Impact factor: 4.335

8.  Discrepancies of assessments in a RECIST 1.1 phase II clinical trial - association between adjudication rate and variability in images and tumors selection.

Authors:  Hubert Beaumont; Tracey L Evans; Catherine Klifa; Ali Guermazi; Sae Rom Hong; Mustapha Chadjaa; Zsuzsanna Monostori
Journal:  Cancer Imaging       Date:  2018-12-11       Impact factor: 3.909

Review 9.  Paperless clinical trials: Myth or reality?

Authors:  Sandeep K Gupta
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200

10.  The impact of data quality and source data verification on epidemiologic inference: a practical application using HIV observational data.

Authors:  Mark J Giganti; Bryan E Shepherd; Yanink Caro-Vega; Paula M Luz; Peter F Rebeiro; Marcelle Maia; Gaetane Julmiste; Claudia Cortes; Catherine C McGowan; Stephany N Duda
Journal:  BMC Public Health       Date:  2019-12-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.